Infectious or noninfectious maternal immune activation (MIA) is an environmental risk factor
for psychiatric and neurological disorders with neurodevelopmental etiologies. Whilst there …

Background Exposure to maternal immune activation (MIA) in utero is a risk factor for
neurodevelopmental disorders later in life. The impact of the gestational timing of MIA …

Maternal immune activation (MIA) caused by exposure to pathogens or inflammation during
critical periods of neurodevelopment is a major risk factor for behavioral deficits and …

Gestational infection is increasingly being recognized for its involvement as causative
mechanism in severe developmental brain abnormalities and its contribution to the …

Maternal infection during pregnancy increases the risk for neurodevelopmental disorders in
offspring. Rodent models have played a critical role in establishing maternal immune …

Despite the potential of rodent models of maternal immune activation (MIA) to identify new
biomarkers and therapeutic interventions for a range of psychiatric disorders, current …

Maternal immune activation (mIA) during pregnancy is hypothesised to disrupt offspring
neurodevelopment and predispose offspring to neurodevelopmental disorders such as …

Maternal immune activation (MIA) at the time of gestation has been linked to increased risk
of neurodevelopmental psychiatric disorders. Animal and human models have been used to …

Maternal immune activation (MIA), be it triggered by infectious or noninfectious stimuli, is
implicated in various psychiatric and neurological disorders with developmental etiologies …

Maternal immune activation (MIA) refers to a maternal immune system triggered by
infectious or infectious‐like stimuli. A cascade of cytokines and immunologic alterations are …